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ABSTRACT
Objective: Sepsis is reported to cause 9.3% death from the total 250,000 patients in the United States. De-escalation of antibiotics is expected to 
increase the effectiveness of therapy, to decrease in the level of antibiotic resistance and to reduce mortality in sepsis patients. The purpose of this 
study was to describe the frequency and characteristics of de-escalation of antibiotics in patients with sepsis and its influence on the patient.
Methods: The study was conducted retrospectively with purposive sampling in hospitalized patients in a hospital in Yogyakarta, to the patients whose 
age are above 15 years, in the month of January to December 2015. Totally, 162 patients were included, in demographic, antibiotic regimens, duration 
of antibiotic treatment, de-escalation of antibiotics treatment, the culture results, mortality, and Length of Stay (LoS).
Result: The result showed that 116 patients were without de-escalation of antibiotics where the majority of cases is the absence of changes in the 
types of antibiotics that are given from the start of the therapy until the treatment is completed. The age of the most sepsis patients treated is about 
46-60 years (36.4%), LoS was 6-10 days highest (27.2%), the number of patients received antibiotics for hospitalized majority 1-2 types of antibiotics 
(46.9%), originally most of the patients’ room are as many as those from emergency unit 63.6%, clinical outcomes patients who were recovered as 
many as 46.3%, the most comorbidities that frequently appear in sepsis patients is pneumonia is 616.6% cases. Patients who were examined culture 
is 29%.
Conclusion: Giving antibiotics are appropriate and adequate to prevent the possibility of resistance and death, and the de-escalation strategy is a 
strategy that is safely used to treat patients with sepsis.
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INTRODUCTION
Sepsis is a disease that often occurs and causes death in patients at 
several hospitals in the United States. It is then forwarded to the aim 
of trying to make a variety of ways or methods to lower the morbidity, 
mortality and appropriate technology approach. In recent years, many 
studies were then conducted by various strategic interventions to 
patients so getting the best clinical outcome [1].
The incidence of prevalence of patients with sepsis in the United 
States was found about 750,000 cases of sepsis in the United States. 
The average occurred in 3 cases out of 100,000 populations. When 
compared with others, acute myocardial infection occurred in a year 
of 900,000 cases while in acute stroke, it occurred in 700,000 cases. 
Simple data on average the largest cause of death in patients can be 
sorted as follows: Sepsis (29%), acute myocardial infarction (25%), and 
stroke (23%). The average increase in patient mortality rate of severe 
sepsis and septic shock is 40% and 50% [1].
Prescribing antibiotics showed a major challenge to the physicians in 
their daily practice, particularly in making sure the design of clinical 
treatment. Thus, to think about it is how to deal with patients with 
severe sepsis therapy fast and precise antibiotic to decrease the 
morbidity and mortality [2]. However, the first phase should identify 
pathogenic bacteria and detect sensitivity to empirical antibiotics 
which would then be stopped or reduced the number of antibiotics 
and changed to a more narrow-spectrum antibiotics. This strategy is 
referred to as de-escalation therapy which turned out to be a right and 
appropriate theory to improve the precision of the appropriate therapy 
and lower the cost of treatment [2-4].
De-escalation of antibiotics is expected to increase the effectiveness of 
therapy. The decrease in the level of antibiotics resistance and to reduce 
the mortality in sepsis patients is high. The purpose of this study was 
to describe the frequency and characteristics of a de-escalation of 
antibiotics in patients with sepsis and its effect on patients.
Antibiotic therapy in sepsis should be given within no more than 1 hr 
after the diagnosis of sepsis is made. Selection is based on the empirical 
antibiotics active against bacteria that cause and reach the source of the 
infection. Infections caused by MultiDrug-Resistant microbes should 
use traditional antibiotic combination. Antibiotics should be evaluated 
daily for the possibility of de-escalation. It should be carried out de-
escalation if the profile has been known sensitivity [5].
MATERIALS AND METHODS
Materials
The material used as the basis for making the data was from the 
patient record diagnosis of sepsis in the inpatient ward during January-
December 2015.
Methods
The researcher conducted a retrospective observational study based on 
medical records in inpatient ward of Dr. Sardjito hospital in Yogyakarta 
from January to December 2015. The study was conducted during 
March-August 2016. The population in this study is adult patients who 
are undergoing sepsis hospitalization in the period and where the 
research took place. Criteria for inclusion of research subjects includes 
adult patients with age >15 years and hospitalized in inpatient wards in 
the period and where the research took place. Research carried out by 
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identifying a subject of research based on pre-defined criteria, recording 
the identity and reviewing their health status, observing the action 
culture specimens of patients, performing the treatment de-escalation 
local doctors and observing the clinical outcomes research subjects. 
Bacteria culture results obtained from data on culture examination 
germs in the patient’s medical record. De-escalation of antibiotic 
treatment of patients was written and grouped by treatment criteria 
and influenced by multiple comorbidities who also suffered sepsis 
patients. The material used as the basis for making the data was from 
the patient record diagnosis of sepsis in the inpatient ward in January-
December 2015. Ethical committee approval in this study was issued 
by Medical and Health Research Ethics Committee (MHREC), Faculty of 
Medicine Universitas Gadjah Mada – Dr. Sardjito General Hospital.
Inclusion criteria
All inpatients, inpatient medicine, age >15 years diagnosed with 
sepsis are recorded in the medical record with clinical and laboratory 
inspection data in accordance with the criteria in the International 
Sepsis Definitions Conference.
Exclusion criteria
Patients whose medical record data are incomplete, lost, or damaged, 
patients who did not receive antibiotics and patients who go home at 
his own request before clinical action is completed.
Data analysis
This research data are the description without intervention so that the 
processing of data was done by grouping based on the problem. The 
calculation is made with the model number and percentage proportion. 
Each data are then analyzed carefully so that the data actually described 
the condition of the patient and the hospital.
RESULTS
This study was conducted using a sample of 162 patients consisted 
of 76 male patients and 86 female patients. From the research, it was 
found that the age of the patients whose age of 46-60 years with a range 
of 36.4% and the youngest is at the age of 76-91 by 10%. Length of stay 
(LoS) for the treatment of sepsis mostly for 6-10 days and antibiotics 
is used as much as 1-2 kinds of antibiotics given to patients (Table 1). 
From Table 2, it is showed that the comorbidities of the diagnosis of 
sepsis patients to the most turned out to be pneumonia [6].
In the management therapy of sepsis patients in internal medicine 
wards, it turns out the treatment in 29% of patients culture, in which 
the culture specimen sampling the vast majority were in sputum that is 
equal to 27.3% of the patients (Table 3). From the results of cultures, it 
showed that most bacteria were found in samples of patient specimens 
are Streptococcus sp. (Fig. 1). Several different bacteria found on culture 
results such as Staphyloccocus coagulase negative and Streptococcus 
viridans. They are often found in the causes of nosocomial infections 
originating from medical devices such as intravenous catheters.[ 5] 
Their Staphylococcus and S. viridans coagulase negative blood cultures 
cannot be set directly as a pathogenic organism for 85% of isolates. 
Staphylococcus coagulase negative and S. viridans produced show 
contaminant organisms.[7]
Antibiotics are used to patients with sepsis in the majority class of 
cephalosporin that is as much as 42.58%, quinolones at 17.48%, as 
much as 10.77% carbapenem, aminoglycoside as much as 9.33%, 
imidazoles as much as 8.85%, others as much as 6, 22%, and macrolides 
Fig. 1: Data germs in sepsis patients
Table 1: Characteristic of adult being diagnosed sepsis patients 
in ward medicine hospital Dr. Sardjito 2015


























Table 2: Data accompanying disease in patients with sepsis
No Accompanying disease Total (%)
1 Pneumonia 60 (16.62)
2 Hipoalbumin 38 (10.53)
3 Diabetes mellitus 32 (8.86)
4 Anemia 27 (7.48)
5 Urinary tract infection 26 (7.20)
6 CKD 23 (6.37)
7 Hypertension 22 (6.09)
8 Febrile neutropenia 15 (4.16)
9 CHF 14 (3.88)
10 Leukemia 13 (3.60)
CKD: Chronic kidney disease, CHF: Congestive heart failure
Tabel 3: The proportion of the culture of the specimen 
treatment
No Tempat specimen kultur Total (%)
1 Sputum 18 (27.3)
2 Blood 12 (18.2)
3 Urine 10 (15.2)
4 Blood wound 5 (7.6)
5 Pus 11 (16.7)
6 Paring swab 4 (6.1)
7 Swab nasofaring 1 (1.5)
8 Faeces 2 (3)
9 Pleura fluid 1 (1.5)
10 Tissue 1 (1.5)
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as much as 4.88%. Other antibiotics in question are clindamycin, 
cotrimoxazole, rifampicin, ampicillin-sulbactam, tetracycline, etc 
(Fig. 2).
The treatment of de-escalation of antibiotics is one solution that is 
expected to be used in the treatment of patients with sepsis. From the 
research results, it was found that patients who receive treatment de-
escalation therapy were 28.4% and that no de-escalation was 71.6%. In 
the act of de-escalation of antibiotics in patients with sepsis, it reduces 
the amount of antibiotics as much as 47.69%, the replacement of 
dosage forms of antibiotics as much as 23.08%, narrowing the 13.85% 
spectrum antibiotic therapy, antibiotic treatment discontinuation and 
dose reduction of antibiotics and 6.15% replacement generation of 
antibiotics to the smaller 3.08% (Table 4) [8-11].
The treatment of non de-escalation occurs in the majority of medical 
action in septic patients in the inpatient. When viewed from the non 
de-escalation it is measured that most antibiotics do not change 
the antibiotic combination of 45.73%, then there is no change of 
antibiotic 29.20%, did not change the spectrum antibiotic 24.09%, the 
replacement of a single antibiotic combination to 3.65% (Table 4) [12].
DISCUSSION
De-escalation of antibiotics is the way of the treatment of pneumonia 
with two important features of the initial broad-spectrum antibiotics 
with high probability that cover all pathogens that may then within 
48-72 hrs followed by the transfer of narrow-spectrum antibiotics 
by microbiological data that may include all germs (pathogens 
causative) [6,13]. An important role in de-escalation is the decision-
making process by choosing a broad-spectrum therapy empirically, 
and policy discontinues antibiotic therapy when the results have been 
negative sputum culture microorganisms, and there are early signs of 
healing. [9,10] De-escalation of antibiotics can also be interpreted as a 
strategy to align user needs adequate initial antibiotic therapy in high-
risk patients to avoid unnecessary use of antibiotics that sparked the 
occurrence of resistance [14,11].
If we look from Fig. 3 we can conclude that the handling of sepsis patients 
in hospitals still needs to be improved. This can be seen by the number 
of patients who died is quite high, especially patients died> 48 hours. 
The amount was balanced with the number of patients who returned 
home the condition improved. Some way out to consider is the problem 
of treatment methods, especially on the appropriate antibiotics of both 
types, amount and time so that the outcome of patients can be better 
condition, especially reducing the number of patients who died to be 
improved or recovered [15].
From Table 5 we can see also that the implementation of antibiotic 
dealing in septic patients in hospitals has not been run in accordance 
with standard therapy. This may be due to several things such as the 
absence of robust microbiological or colonization data, conditions of 
disease complications and multi-resistance to antibiotics. Whereas in 
some research found that the implementation of antibiotic dehaling 
can decrease the incidence of antibiotic resistance, improving patient 
clinical outcome condition, and increasing cost effectiveness. By 
looking at some of the benefits of this antibiotic de-alteration then what 
may need to be done is to make a clear guidance to the physician that 
contains practical steps on how to do antibiotic dealing with a septic 
patient. [15,16]
Broad-spectrum antibiotic treatment in empirical
Interest de-escalation of antibiotics that have been mentioned above 
to minimize the resistance of germs to antibiotics and lower the 
cost of treatment. The broad-spectrum antibiotics are capable and 
effective against Gram-negative and Gram-positive and should be given 
immediately if there are signs of infection. This is done to prevent the high 
number of deaths, prevent dysfunction organ and reduce the number 
of hospitalizations due to inadequate early treatment. The broad-
spectrum antibiotics should also take into account the microbiological 
data and local patterns resistention. The principle strategy of de-
escalation is a strategy in a way that adequately antibiotics (potent) 
since the beginning of therapy to patients who have high-risk factors to 
avoid the use of antibiotics is not quite right. Antibiotics are inadequate 
and inaccurate that can lead to resistance. Another de-escalation 
Fig. 2: Proportion of antibiotics used in sepsis patients
Fig. 3: Data clinical outcome of sepsis patients
Table 4: De-escalation antibiotics pattern sepsis patients
Treatment of antibiotic therapy Procedures therapy Total (%)
De-escalation Replacement of the dosage form antibiotic 15 (23.08)
Antibiotic dose reduction 4 (6.15)
Treatment discontinuation antibiotic 4 (6.15)
Narrow spectrum antibiotic therapy 9 (13.85)
Reducing the amount of antibiotics 31 (47.69)
Replacement antibiotic to smaller generation 2 (3.08)
Total 65 (100)
Non de-escalation Do not change the spectrum antibiotic 33 (24.09)
There is no change antibiotic 40 (29.2)
Replacement of antibiotic single to combination 5 (3.65)
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strategy is to shorten the duration of administration of broad-spectrum 
antibiotics. Simplifying therapy becomes more narrow spectrum 
antibiotic and stop if cultures are negative bacteria as well as clinical 
improvement occurs. The strategy is done by providing initial therapy 
no more than 4 hrs since patients in the intensive care unit with broad-
spectrum antibiotics with high dose based on the pattern of bacteria 
microbiology local to lower mortality, prevent organ dysfunction 
and shorten the LoS and to optimize the therapeutic de-escalation to 
minimize resistance and save on the cost of treatment [2,17].
Giving antibiotics and dosage adequate accurately
Hospital-acquired pneumonia patient’s recovery can be achieved with 
the right combination of antibiotics and germs cause is still sensitive to 
these antibiotics as well as the provision of adequate antibiotic therapy. 
Appropriate antibiotic therapy and adequate in terms of the proper 
dosage (optimal dosage), the drug can reach the site of infection/
penetration into the tissue to cure the infection, antibiotics right way 
either intravenously or orally as well as in combination antibiotic 
therapy if possible. Giving a history of appropriate antibiotic therapy is 
one of the conditions of success managing severe sepsis and pneumonia. 
Determination of antibiotics should be based on knowledge of existing 
microorganisms, bacteria resistance patterns at the local site, the choice 
of drugs based on rational considerations [6,18]. Giving antibiotics is 
adequate since the beginning can improve survival rates.
The combination therapy and monotherapy award
Several strategies have been suggested in the unnecessary use of 
antibiotics as a trigger of the resistance of germs. The main objective of de-
escalation is trying to replace empirical treatment regimens combined 
into a monotherapy regimen to prevent resistance during treatment. At 
the American Thoracic Society-Infectious Diseases Society of America 
guidelines, it is said that patients with risk factors for tuberculosis (TB) 
germs suggested getting initial treatment with combination regimens 
that aim is to provide simple treatment that could include suspects 
multiple drug resistance (MDR) bacteria. Administration of drugs 
monotherapy in bacteria Pseudomonas aeruginosa and Enterobacter 
spp. is likely to cause drug resistance, for instance, given an only class of 
third generation cephalosporins [3]. Broad-spectrum antibiotic therapy 
should be added so that it gives the combination therapy to fight the 
germs that cause TB. Combined antibiotic combination therapy should 
be of a different class of therapeutic mechanisms to prevent antagonists. 
Combination therapy usually Gram-negative bacteria from the class of 
β-lactams, quinolones, or aminoglycosides. Although the combination 
of the quinolone class of better penetration than aminoglycosides and 
toxic effects to the kidneys is lower cure rates with drug combinations 
with aminoglycosides go on further [11].
Administration of drugs with monotherapy should be administered 
optimally. There are four criteria for combination therapy of antibiotics. 
First is when the combination provides synergy. The second is when 
the germs enter the category of weight and have not been identified. 
Third, if it can be proved that the combination therapy could delay the 
onset of resistance and the fourth case is a mixed infection of Gram-
positive bacteria, Gram-negative, and anaerobes. If these criteria are 
met and implemented correctly, it is little possible to the occurrence of 
MDR [19,14,20].
De-escalation narrow spectrum antibiotics
There are several steps in the strategy of de-escalation of antibiotics: 
Starting with the administration of empirical antibiotic broad-spectrum 
with the aim of preventing the occurrence of therapy inadequate and 
inaccurate, change the treatment of a broad-spectrum into a narrow 
spectrum, reduction the duration of treatment and discontinue 
treatment based on the clinical response of patients and results 
microbiological cultures. De-escalation can be done if the culture 
results of data microbiology and germ profile have been out after a few 
days which is about 24-72 hrs to give a narrow spectrum antibiotic 
regimen or even stop the antibiotic if necessary. This strategy must 
be safe and appropriate in a change of combination therapy became 
monotherapy. This strategy should be based on microbiological data 
before it is treated. Negative cultures or bacteria were not found, and 
the clinical response of patients showed improvement after 2-3 days 
with treatment. The benefits of this strategy are that it can reduce 
cost, reduce mortality and morbidity due to inadequate antibiotic 
treatment [6,14].
Therapeutic de-escalation can be performed on patients who 
demonstrated clinical response and more focused on the improvement 
of certain antibiotics as well as if there are no bacteria such as 
P. aeruginosa or Acinetobacter spp. Microbiological examination and 
cultures of microorganisms cultured specimens are still sensitive to the 
antibiotic lower orders.
Shortening duration of antibiotics
Shortening the duration or timing of empirical antibiotic therapy is 
shortened from a broad-spectrum approach de-escalation that can 
reduce the side effects of antibiotics and prevent the risk of germs 
against colonization and the growth of bacteria that are resistant to 
antibiotics as a result of antibiotic treatment is too long. Antibiotics 
briefly associated with a lower risk of antibiotic resistance compared 
to treatment with a time span of 14-21 days but if germs are not 
P. aeruginosa, the duration of antibiotic treatment could be shortened 
to 7-8 days [20,21].
Rather therapy (switch therapy)
The period of hospitalization should be shortened because it may reduce 
antibiotic resistance. The strategy by doing a parenteral antibiotic 
therapy to oral antibiotics is effective in the treatment of serious 
infections. In the execution of transfer therapy can be done by a step-
down therapy, sequential therapy, and switchover. Sequential therapy 
is shifting from intravenous to oral medication with the principle of 
adequate serum drug levels and maintained so that the drug levels are 
achieved intravenous and oral is the same as doxycycline, linezolid, and 
class quinolones such as levofloxacin and moxifloxacin. The transfer of 
oral therapy was associated with decreased serum drug levels compared 
with a step-down therapy intravenous known as third generation 
cephalosporin intravenously into oral amoxicillin or erythromycin. 
While the term switchover is the transfer of different types of drugs, 
but with the same drug levels, e.g. third generation cephalosporin 
intravenously into oral ciprofloxacin. Terms of the oral dosage must 
have pharmacokinetic properties and are able to achieve the target 
organ with levels above the minimum inhibitory concentration (MIC) 
so that it can eradicate infection-causing germs. One of the criteria 
pharmacokinetics of an oral antibiotic that can be used to control drug 
therapy was common ground potential or area under the curve with 
sediaan intravena or near 100%, but the most important thing is the 
ability of the drug reaches the target organ with the same level or above 
the MIC. Some of the benefits obtained from the transfer of antibiotic 
therapy, these include the giving and administration of intravenous 
antibiotics reduce complications, improve patient compliance, reduce 
the incidence of pulmonary infection-causing germs resistance to 
antibiotics and can reduce the cost of care. Selection of antibiotics 
for this purpose can be done empirically and should be based on the 
pattern of resistance-causing germs and antibiotic resistance test data 
obtained locally [21].
CONCLUSION
Giving antibiotics are appropriate and adequate to prevent the 
possibility of resistance and death and the de-escalation strategy is a 
strategy that is safely used to treat patients with sepsis.
Table 5: Proportion of de-escalation antibiotic treatment of 
sepsis patients
No Treatment Total (%)
1 De-escalation 46 (28.4)
2 Non de-escalation 116 (71.6)
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